Connect with us

Technology

J.P. Morgan healthcare conference topics January 7

Published

on

[ad_1]

Jamie DimonJPMorgan CEO Jamie Dimon.Chip Somodevilla / Getty Images

Starting Monday, thousands of pharmaceutical industry executives, investors, bankers, and analysts will swarm into San Francisco for the J.P. Morgan Healthcare Conference.

Now in its 37th year, the conference has ballooned from a small event with 150 attendees that was essentially the “birth of biotech,” to an event attended by everyone from the biggest pharma company to the smallest biotech. JPMorgan said more than 485 companies are scheduled to present this year.

It’s a spot for these companies to meet with investors and each other, and can be the starting point for takeovers or other deals. 

It’s also a place where more deals — maybe even on the scale of Thursday’s $74 billion merger between Bristol-Myers Squibb and Celgene — could get announced. 

From confronting the threat of technology giants’ healthcare advances to covering the cost of one-time treatments, here are some of the key topics we’ll be asking about this week. 

We’ll be sending out our best stories from the week in Dispensed, our weekly dispatch of pharma, biotech, and healthcare news. Sign up here.


The annual J.P. Morgan Healthcare Conference…

The biggest healthcare investor conference starts on Monday — here are the top 5 areas we’re keeping an eye on

Health,JPM19,Bristol-myers Squibb,Celgene,Biotech,GW Pharma,Cigna,Express Scripts,Amazon,CVS Health,Features

The biggest healthcare investor conference starts on Monday — here are the top 5 areas we’re keeping an eye on

2019-01-04T22:21:00+01:00

2019-01-04T16:28:57+01:00

2019-01-04T22:21:08+01:00

https://static4.businessinsider.de/image/599c4375d030203f5d3450cc-500-250/the-biggest-healthcare-investor-conference-starts-on-monday–here-are-the-top-5-areas-were-keeping-an-eye-on.jpg

BusinessInsiderDe



The annual J.P. Morgan Healthcare Conference kicks off on January 7 in San Francisco. 
The event is the start to an already-busy year for biotech, pharma, and healthcare executives. 
From Amazon’s healthcare ambitions, to who will pull off the next mega-merger, here’s what we expect to hear a lot about next week. 

Starting Monday, thousands of pharmaceutical industry executives, investors, bankers, and analysts will swarm into San Francisco for the J.P. Morgan Healthcare Conference.Now in its 37th year, the conference has ballooned from a small event with 150 attendees that was essentially the “birth of biotech,” to an event attended by everyone from the biggest pharma company to the smallest biotech. JPMorgan said more than 485 companies are scheduled to present this year.
It’s a spot for these companies to meet with investors and each other, and can be the starting point for takeovers or other deals. 
It’s also a place where more deals — maybe even on the scale of Thursday’s $74 billion merger between Bristol-Myers Squibb and Celgene — could get announced. 
From confronting the threat of technology giants’ healthcare advances to covering the cost of one-time treatments, here are some of the key topics we’ll be asking about this week. 
We’ll be sending out our best stories from the week in Dispensed, our weekly dispatch of pharma, biotech, and healthcare news. Sign up here.

international

The annual J.P. Morgan Healthcare Conference…

The biggest healthcare investor conference starts on Monday — here are the top 5 areas we’re keeping an eye on

Health,JPM19,Bristol-myers Squibb,Celgene,Biotech,GW Pharma,Cigna,Express Scripts,Amazon,CVS Health,Features

The biggest healthcare investor conference starts on Monday — here are the top 5 areas we’re keeping an eye on

2019-01-04T22:21:00+01:00

2019-01-04T22:21:08+01:00

https://static4.businessinsider.de/image/599c4375d030203f5d3450cc-500-250/the-biggest-healthcare-investor-conference-starts-on-monday–here-are-the-top-5-areas-were-keeping-an-eye-on.jpg

BusinessInsiderDe



The annual J.P. Morgan Healthcare Conference kicks off on January 7 in San Francisco. 
The event is the start to an already-busy year for biotech, pharma, and healthcare executives. 
From Amazon’s healthcare ambitions, to who will pull off the next mega-merger, here’s what we expect to hear a lot about next week. 

Starting Monday, thousands of pharmaceutical industry executives, investors, bankers, and analysts will swarm into San Francisco for the J.P. Morgan Healthcare Conference.Now in its 37th year, the conference has ballooned from a small event with 150 attendees that was essentially the “birth of biotech,” to an event attended by everyone from the biggest pharma company to the smallest biotech. JPMorgan said more than 485 companies are scheduled to present this year.
It’s a spot for these companies to meet with investors and each other, and can be the starting point for takeovers or other deals. 
It’s also a place where more deals — maybe even on the scale of Thursday’s $74 billion merger between Bristol-Myers Squibb and Celgene — could get announced. 
From confronting the threat of technology giants’ healthcare advances to covering the cost of one-time treatments, here are some of the key topics we’ll be asking about this week. 
We’ll be sending out our best stories from the week in Dispensed, our weekly dispatch of pharma, biotech, and healthcare news. Sign up here.

international

[ad_2]

Source link

قالب وردپرس

Technology

More groups join in support of women in STEM program at Carleton

Published

on

By

OTTAWA — Major companies and government partners are lending their support to Carleton University’s newly established Women in Engineering and Information Technology Program.

The list of supporters includes Mississauga-based construction company EllisDon.

The latest to announce their support for the program also include BlackBerry QNX, CIRA (Canadian Internet Registration Authority), Ericsson, Nokia, Solace, Trend Micro, the Canadian Nuclear Safety Commission, CGI, Gastops, Leonardo DRS, Lockheed Martin Canada, Amdocs and Ross.

The program is officially set to launch this September.

It is being led by Carleton’s Faculty of Engineering and Design with the goal of establishing meaningful partnerships in support of women in STEM.  

The program will host events for women students to build relationships with industry and government partners, create mentorship opportunities, as well as establish a special fund to support allies at Carleton in meeting equity, diversity and inclusion goals.

Continue Reading

Technology

VR tech to revolutionize commercial driver training

Published

on

By

Serious Labs seems to have found a way from tragedy to triumph? The Edmonton-based firm designs and manufactures virtual reality simulators to standardize training programs for operators of heavy equipment such as aerial lifts, cranes, forklifts, and commercial trucks. These simulators enable operators to acquire and practice operational skills for the job safety and efficiency in a risk-free virtual environment so they can work more safely and efficiently.

The 2018 Humboldt bus catastrophe sent shock waves across the industry. The tragedy highlighted the need for standardized commercial driver training and testing. It also contributed to the acceleration of the federal government implementing a Mandatory Entry-Level Training (MELT) program for Class 1 & 2 drivers currently being adopted across Canada. MELT is a much more rigorous standard that promotes safety and in-depth practice for new drivers.

Enter Serious Labs. By proposing to harness the power of virtual reality (VR), Serious Labs has earned considerable funding to develop a VR commercial truck driving simulator.

The Government of Alberta has awarded $1 million, and Emissions Reduction Alberta (ERA) is contributing an additional $2 million for the simulator development. Commercial deployment is estimated to begin in 2024, with the simulator to be made available across Canada and the United States, and with the Alberta Motor Transport Association (AMTA) helping to provide simulator tests to certify that driver trainees have attained the appropriate standard. West Tech Report recently took the opportunity to chat with Serious Labs CEO, Jim Colvin, about the environmental and labour benefits of VR Driver Training, as well as the unique way that Colvin went from angel investor to CEO of the company.

Continue Reading

Technology

Next-Gen Tech Company Pops on New Cover Detection Test

Published

on

By

While the world comes out of the initial stages of the pandemic, COVID-19 will be continue to be a threat for some time to come. Companies, such as Zen Graphene, are working on ways to detect the virus and its variants and are on the forefronts of technology.

Nanotechnology firm ZEN Graphene Solutions Ltd. (TSX-Venture:ZEN) (OTCPK:ZENYF), is working to develop technology to help detect the COVID-19 virus and its variants. The firm signed an exclusive agreement with McMaster University to be the global commercializing partner for a newly developed aptamer-based, SARS-CoV-2 rapid detection technology.

This patent-pending technology uses clinical samples from patients and was funded by the Canadian Institutes of Health Research. The test is considered extremely accurate, scalable, saliva-based, affordable, and provides results in under 10 minutes.

Shares were trading up over 5% to $3.07 in early afternoon trade.

Continue Reading

Chat

Trending